This study was conducted to isolate a compound with anticancer properties from the roots of Peucedanum japonicum Thunb. (Umbelliferae), and to evaluate the efficacy of that compound’s anticancer activity. The CHCl 3 layer was purified via repeated column chromatography and recrystallization. The two compounds isolated from CHCl 3 layer were identified via NMR spectroscopic analysis as (10E) 1,10-heptadecadiene-4,6-diyne-3,8,9-triol (Comp. I) and anomalin (Comp. II). (10E) 1,10-heptadecadiene-4,6-diyne-3,8,9-triol was the first report from the roots of P. japonicum. MTT assays were conducted to evaluate the in vitro cytotoxic activities of Compounds I and II against the following human cancer cell lines: HeLa, HepG2, SNU-16, and AGS. Comp. I evidenced the most profound cytotoxic activity against HepG2 cells (IC 50 = 6.04 ㎍/mL), and Comp. II exhibited the most profound cytotoxic activity against SNU-16 cells (IC 50 = 18.24 ㎍/mL) among the human cancer cell lines tested in this study. However, no significant cell death was observed in the CCD-25Lu human normal lung fibroblast cells. Quantitative analysis using UPLC (Ultra Performance Liquid Chromatography) showed that the roots of P. japonicum contained 0.015 (Comp. I) and 1.69 ㎎/g (Comp. II) of these compounds.
Introduction
Materials and Methods
Results and Discussion
Acknowledgment
References